Eastern Canadian Colorectal Cancer Consensus Conference 2013: Emerging Therapies in the Treatment of Pancreatic, Rectal, and Colorectal Cancers
T. Di Valentin(Sunnybrook Health Science Centre), Rachel Goodwin(University of Ottawa), Rakesh Goel(Ottawa Hospital), Jamil Asselah(McGill University), James Biagi(Queen's University), David Roberge(Centre Hospitalier de l’Université de Montréal), Michael P. Thirlwell(McGill University Health Centre), Laura A. Dawson(Princess Margaret Cancer Centre), Brian Colwell, F. Aubin(Centre Hospitalier Universitaire de Besançon), Stephanie Snow(Dalhousie University), Natalie G. Coburn(Malaysian Cocoa Board), Samantha Gray(Queen Elizabeth II Health Sciences Centre), Derek J. Jonker(University of Ottawa), Nazik Hammad(St. Michael's Hospital), Mustapha Tehfé(Centre Hospitalier de l’Université de Montréal), Elena Tsvetkova(St Petersburg University), Nathalie Aucoin(McGill University Health Centre), C. Cripps(Canadian Partnership Against Cancer), Wael Shabana(Ottawa Hospital), Marko Šimunović, Ronald L. Burkes(Mount Sinai Hospital), Dominique Frechette, M. Dorreen(Saint John Regional Hospital), Melanie Seal(Dr. H. Bliss Murphy Cancer Centre), Benoît Samson(Hôpital Charles-Le Moyne), Scott Berry(Multiple Sclerosis Foundation), Jean A. Maroun(American Society of Clinical Oncology), Timothy R. Asmis(Ottawa Hospital), Chris Booth(Ottawa Hospital), Sulaiman Nanji(Queen's University), T. Vuong(Sunnybrook Health Science Centre), Michael M. Vickers(Ottawa Hospital), Petr Kavan(Université Paris Cité)
Cited by 2
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Cetuximab for the Treatment of Colorectal Cancer
|New England Journal of Medicine|2007|1.8k
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
|Journal of Clinical Oncology|2004|1.5k